Molecular and clinical subgroup analyses from a phase III trial comparing gefitinib with docetaxel in previously treated non-small cell lung cancer (INTEREST) ...
Deacetylase inhibitor (DACI) panobinostat in relapsed small cell lung cancer (SCLC) patients: Results of a multicenter phase II trial. Phase II trial of R-(-)-gossypol acetic acid (NSC 726190, AT-101) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback